《拜杜法案》对发展中国家有益吗？来自美国经验的教训。
Is Bayh-Dole good for developing countries? Lessons from the US experience.
作者信息
So Anthony D, Sampat Bhaven N, Rai Arti K, Cook-Deegan Robert, Reichman Jerome H, Weissman Robert, Kapczynski Amy
机构信息
Center for Strategic Philanthropy and Civil Society, Terry Sanford Institute of Public Policy, Duke University and Duke Global Health Institute, Durham, North Carolina, United States of America.
出版信息
PLoS Biol. 2008 Oct 28;6(10):e262. doi: 10.1371/journal.pbio.0060262.
Abstract
The US Bayh-Dole Act encourages university patenting of inventions arising from publicly funded research. Lessons from three decades of US experience serve as a cautionary tale for those countries that may choose to emulate Bayh-Dole.
摘要
美国的《拜杜法案》鼓励大学为公共资助研究产生的发明申请专利。美国三十年经验中的教训，对于那些可能选择效仿《拜杜法案》的国家而言，是一个警示故事。
相似文献
1
Is Bayh-Dole good for developing countries? Lessons from the US experience.《拜杜法案》对发展中国家有益吗？来自美国经验的教训。
PLoS Biol. 2008 Oct 28;6(10):e262. doi: 10.1371/journal.pbio.0060262.
2
Intellectual property. University licensing and the Bayh-Dole Act.知识产权。大学许可与《拜杜法案》。
Science. 2003 Aug 22;301(5636):1052. doi: 10.1126/science.1087473.
3
Bayh-Dole: if we knew then what we know now.拜杜法案：要是我们当时就知道现在所知道的情况就好了。
Nat Biotechnol. 2006 Mar;24(3):320-3. doi: 10.1038/nbt0306-320.
4
Bayh-Dole: almost 25.拜杜法案：近25年。 （此翻译需结合具体语境理解其准确含义，这里只是按字面翻译）
Science. 2005 Mar 4;307(5714):1375. doi: 10.1126/science.1107581.
5
March-in rights under the Bayh-Dole Act: the NIH's paper tiger?《拜杜法案》下的 march-in 权利：美国国立卫生研究院的纸老虎？
Seton Hall Law Rev. 2013 Nov 1;43(4):1403-32.
6
Patents, profits, and the American people--the Bayh-Dole Act of 1980.专利、利润与美国民众——1980年的《拜杜法案》
N Engl J Med. 2013 Aug 29;369(9):794-6. doi: 10.1056/NEJMp1306553.
7
Lessons from Bayh-Dole.拜杜法案的经验教训。
Nature. 2010 Dec 9;468(7325):755-6. doi: 10.1038/468755a.
8
Can we expect to achieve anything from Indian Bayh Dole?
Indian J Med Res. 2009 Oct;130(4):487.
9
Research interactions between industry and academia: a corporate perspective.产业界与学术界之间的研究互动：企业视角。
Physiologist. 1996 Jun;39(3):81, 90-2.
10
The Bayh-Dole Act turns 30.《拜杜法案》迎来 30 周年。
Sci Transl Med. 2010 Oct 6;2(52):52cm27. doi: 10.1126/scitranslmed.3001481.
引用本文的文献
1
Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change.改革创新体系以提供可负担药品：作为复杂适应系统（森林）的药物创新概念框架及变革理论。
J Pharm Policy Pract. 2025 Jan 16;18(1):2436899. doi: 10.1080/20523211.2024.2436899. eCollection 2025.
2
Essential medicines for universal health coverage.全民健康覆盖的基本药物。
Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8.
3
When Copyright Law and Science Collide: Empowering Digitally Integrated Research Methods on a Global Scale.当版权法与科学发生冲突时：在全球范围内推动数字集成研究方法
Minn Law Rev. 2012 Jul 1;96(4):1362-1480.
4
Patenting and the gender gap: should women be encouraged to patent more?专利与性别差距：是否应该鼓励女性申请更多专利？
Sci Eng Ethics. 2013 Jun;19(2):491-504. doi: 10.1007/s11948-011-9344-5. Epub 2012 Jan 3.
5
An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.影响药物研发的主要立法的实证回顾：过去的经验、影响和意外后果。
Milbank Q. 2011 Sep;89(3):450-502. doi: 10.1111/j.1468-0009.2011.00636.x.
6
Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results.德国大学和非大学公共研究机构的专利：来自医学研究成果专利申请的证据。
PLoS One. 2010 Nov 18;5(11):e14059. doi: 10.1371/journal.pone.0014059.
7
The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond.针对被忽视疾病及其他疾病的化合物，高校独家许可政策的无声蔓延。
PLoS Negl Trop Dis. 2010 Mar 30;4(3):e570. doi: 10.1371/journal.pntd.0000570.
8
Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.哥伦比亚大学的阿克塞尔专利：技术转让及其对《拜杜法案》的影响
Milbank Q. 2009 Sep;87(3):683-715. doi: 10.1111/j.1468-0009.2009.00575.x.
9
The Bayh-Dole Act: a model for promoting research translation?《拜杜法案》：促进研究成果转化的典范？
Mol Oncol. 2009 Apr;3(2):91-3. doi: 10.1016/j.molonc.2008.12.004. Epub 2008 Dec 24.
本文引用的文献
1
Intellectual property. U.S. Patent Office casts doubt on Wisconsin stem cell patents.知识产权。美国专利局对威斯康星州的干细胞专利提出质疑。
Science. 2007 Apr 13;316(5822):182. doi: 10.1126/science.316.5822.182.
2
Patent buy-outs for global disease innovations for low- and middle-income countries.
Am J Law Med. 2006;32(2-3):159-73. doi: 10.1177/009885880603200202.
3
Intellectual property rights. Public sector collaboration for agricultural IP management.知识产权。公共部门在农业知识产权管理方面的协作。
Science. 2003 Jul 11;301(5630):174-5. doi: 10.1126/science.1085553.
4
Science and the law. Working through the patent problem.科学与法律。解决专利问题。
Science. 2003 Feb 14;299(5609):1021. doi: 10.1126/science.299.5609.1021.
5
Patents and innovation in cancer therapeutics: lessons from CellPro.癌症治疗领域的专利与创新：来自赛尔普罗公司的经验教训
Milbank Q. 2002;80(4):637-76, iii-iv. doi: 10.1111/1468-0009.00027.
6
Data withholding in academic genetics: evidence from a national survey.学术遗传学中的数据隐瞒：一项全国性调查的证据
JAMA. 2002;287(4):473-80. doi: 10.1001/jama.287.4.473.
7
Bermuda rules: community spirit, with teeth.百慕大规则：带“牙齿”的社区精神。
Science. 2001 Feb 16;291(5507):1192. doi: 10.1126/science.291.5507.1192.
8
Can patents deter innovation? The anticommons in biomedical research.专利会阻碍创新吗？生物医学研究中的反公地悲剧。
Science. 1998 May 1;280(5364):698-701. doi: 10.1126/science.280.5364.698.
9
Looking a gift horse in the mouth: corporate gifts supporting life sciences research.对礼物吹毛求疵：支持生命科学研究的企业礼品
JAMA. 1998 Apr 1;279(13):995-9. doi: 10.1001/jama.279.13.995.
10
Primate embryonic stem cells.灵长类胚胎干细胞。
Curr Top Dev Biol. 1998;38:133-65. doi: 10.1016/s0070-2153(08)60246-x.
Zotero 插件